{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:58:34Z","timestamp":1792468714843,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"am","delay-in-days":338,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["14-CE-0026"],"award-info":[{"award-number":["14-CE-0026"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.autrev.2019.102361","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T12:52:44Z","timestamp":1565268764000},"page":"102361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"title":["Monogenic lupus: Dissecting heterogeneity"],"prefix":"10.1016","volume":"18","author":[{"given":"Ommar","family":"Omarjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Frachette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Moreews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Rieux-Laucat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Soulas-Sprauel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Viel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Lega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Bader-Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Walzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Cimaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Belot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.autrev.2019.102361_bb0005","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2019.102361_bb0010","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.autrev.2018.01.007","volume":"17","author":"Hartman","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.102361_bb0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2014.01.004","article-title":"Diagnostic criteria for systemic lupus erythematosus: a critical review","volume":"48\u201349","author":"Yu","year":"2014","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.autrev.2019.102361_bb0020","first-page":"176","article-title":"The genetic contribution to systemic lupus erythematosus","volume":"66","author":"Criswell","year":"2008","journal-title":"Bull NYU Hosp Jt Dis"},{"issue":"12","key":"10.1016\/j.autrev.2019.102361_bb0025","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/art.30603","article-title":"Lupus: how much \u201ccomplexity\u201d is really (just) genetic heterogeneity?","volume":"63","author":"Crow","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2019.102361_bb0030","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/ng.3434","article-title":"Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus","volume":"47","author":"Bentham","year":"2015","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.autrev.2019.102361_bb0035","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ng.3603","article-title":"Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus","volume":"48","author":"Morris","year":"2016","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.autrev.2019.102361_bb0040","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.autrev.2017.12.011","article-title":"Genetic variation and systemic lupus erythematosus: a field synopsis and systematic meta-analysis","volume":"17","author":"Jeong","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2019.102361_bb0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/BOR.0000000000000411","article-title":"Genetic advances in systemic lupus erythematosus: an update","volume":"29","author":"Chen","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2019.102361_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaut.2013.01.008","article-title":"Genetic susceptibility to SLE: recent progress from GWAS","volume":"41","author":"Cui","year":"2013","journal-title":"J Autoimmun"},{"issue":"7265","key":"10.1016\/j.autrev.2019.102361_bb0055","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex diseases","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.autrev.2019.102361_bb0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng0598-56","article-title":"Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies","volume":"19","author":"Botto","year":"1998","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.autrev.2019.102361_bb0065","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1177\/0961203316676382","article-title":"An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus","volume":"26","author":"Carbonella","year":"2017","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.autrev.2019.102361_bb0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cell.2016.05.034","article-title":"Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity","volume":"166","author":"Sisirak","year":"2016","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.autrev.2019.102361_bb0075","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri3850","article-title":"Aicardi-Gouti\u00e8res syndrome and the type I interferonopathies","volume":"15","author":"Crow","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2019.102361_bb0080","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ni0901-764","article-title":"Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity","volume":"2","author":"Lipsky","year":"2001","journal-title":"Nat Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2019.102361_bb0085","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/art.38008","article-title":"Protein kinase c\u03b4 deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation","volume":"65","author":"Belot","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"6883","key":"10.1016\/j.autrev.2019.102361_bb0090","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/416860a","article-title":"Protein kinase Cdelta controls self-antigen-induced B-cell tolerance","volume":"416","author":"Mecklenbr\u00e4uker","year":"2002","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.autrev.2019.102361_bb0095","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/art.40452","article-title":"Review: cell death, nucleic acids, and immunity: inflammation beyond the grave","volume":"70","author":"Elkon","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2019.102361_bb0100","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nri3607","article-title":"Apoptotic cell clearance: basic biology and therapeutic potential","volume":"14","author":"Poon","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2019.102361_bb0105","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1136\/annrheumdis-2014-205287","article-title":"The complement system in systemic lupus erythematosus: an update","volume":"73","author":"Leffler","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2019.102361_bb0110","doi-asserted-by":"crossref","first-page":"J276","DOI":"10.1016\/j.jaut.2009.11.014","article-title":"The complement system in systemic autoimmune disease","volume":"34","author":"Chen","year":"2010","journal-title":"J Autoimmun"},{"issue":"6","key":"10.1016\/j.autrev.2019.102361_bb0115","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/00008480-199810060-00011","article-title":"Complement deficiency and autoimmunity","volume":"10","author":"Sullivan","year":"1998","journal-title":"Curr Opin Pediatr"},{"issue":"10","key":"10.1016\/j.autrev.2019.102361_bb0120","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1002\/art.24852","article-title":"C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis","volume":"60","author":"Lood","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"6388","key":"10.1016\/j.autrev.2019.102361_bb0125","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1126\/science.aao4555","article-title":"C1q restrains autoimmunity and viral infection by regulating CD8+ T cell metabolism","volume":"360","author":"Ling","year":"2018","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.autrev.2019.102361_bb0130","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1084\/jem.173.5.1083","article-title":"Molecular interactions of complement receptors on B lymphocytes: a CR1\/CR2 complex distinct from the CR2\/CD19 complex","volume":"173","author":"Tuveson","year":"1991","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.autrev.2019.102361_bb0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1084\/jem.173.1.55","article-title":"Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19","volume":"173","author":"Matsumoto","year":"1991","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.autrev.2019.102361_bb0140","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nrrheum.2012.75","article-title":"Complement in the immunopathogenesis of rheumatic disease","volume":"8","author":"Sturfelt","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2019.102361_bb0145","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1742-4658.2008.06849.x","article-title":"Murine serum nucleases \u2013 contrasting effects of plasmin and heparin on the activities of DNase1 and DNase1-like 3 (DNase1l3)","volume":"276","author":"Napirei","year":"2009","journal-title":"FEBS J"},{"issue":"4","key":"10.1016\/j.autrev.2019.102361_bb0150","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/91070","article-title":"Mutation of DNASE1 in people with systemic lupus erythematosus","volume":"28","author":"Yasutomo","year":"2001","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.autrev.2019.102361_bb0155","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1002\/art.20721","article-title":"Novel DNASE I mutations related to systemic lupus erythematosus","volume":"50","author":"Boda\u00f1o","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2019.102361_bb0160","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.immuni.2016.04.002","article-title":"Recognition of endogenous nucleic acids by the innate immune system","volume":"44","author":"Roers","year":"2016","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.autrev.2019.102361_bb0165","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/art.38010","article-title":"DNASE1L3 mutations in hypocomplementemic urticarial vasculitis syndrome","volume":"65","author":"Oz\u00e7akar","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2019.102361_bb0170","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/ng.975","article-title":"Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus","volume":"43","author":"Al-Mayouf","year":"2011","journal-title":"Nat Genet"},{"issue":"157","key":"10.1016\/j.autrev.2019.102361_bb0175","doi-asserted-by":"crossref","first-page":"157ra141","DOI":"10.1126\/scitranslmed.3004801","article-title":"NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus","volume":"4","author":"Campbell","year":"2012","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.autrev.2019.102361_bb0180","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92920","article-title":"Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps","volume":"2","author":"Kienh\u00f6fer","year":"2017","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.autrev.2019.102361_bb0185","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.4049\/jimmunol.1700774","article-title":"Cutting edge: processing of oxidized peptides in macrophages regulates T cell activation and development of autoimmune arthritis","volume":"199","author":"Yang","year":"2017","journal-title":"J Immunol"},{"issue":"3859","key":"10.1016\/j.autrev.2019.102361_bb0190","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1126\/science.162.3859.1277","article-title":"Deficiency of reduced nicotinamide-adenine dinucleotide oxidase in chronic granulomatous disease","volume":"162","author":"Baehner","year":"1968","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.autrev.2019.102361_bb0195","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJM196805022781801","article-title":"Quantitative nitroblue tetrazolium test in chronic granulomatous disease","volume":"278","author":"Baehner","year":"1968","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.autrev.2019.102361_bb0200","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaci.2008.07.050","article-title":"Chronic granulomatous disease as a risk factor for autoimmune disease","volume":"122","author":"De Ravin","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2019.102361_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2017.02.029","article-title":"Inflammatory and autoimmune manifestations in X-linked carriers of chronic granulomatous disease in the United Kingdom","volume":"140","author":"Battersby","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2019.102361_bb0210","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/rheumatology\/kei135","article-title":"Abnormal apoptosis in chronic granulomatous disease and autoantibody production characteristic of lupus","volume":"45","author":"Sanford","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2019.102361_bb0215","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2249.2007.03321.x","article-title":"Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology","volume":"148","author":"Cale","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2019.102361_bb0220","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.autrev.2017.07.001","article-title":"Does type-I interferon drive systemic autoimmunity?","volume":"16","author":"Picard","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2019.102361_bb0225","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ana.410150109","article-title":"A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis: Aicardi and Goutieres: basal ganglia calcifications","volume":"15","author":"Aicardi","year":"1984","journal-title":"Ann Neurol"},{"issue":"2\u20133","key":"10.1016\/j.autrev.2019.102361_bb0230","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0022-510X(88)90125-6","article-title":"Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy","volume":"84","author":"Lebon","year":"1988","journal-title":"J Neurol Sci"},{"issue":"8","key":"10.1016\/j.autrev.2019.102361_bb0235","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/ng1845","article-title":"Mutations in the gene encoding the 3\u2032-5\u2032 DNA exonuclease TREX1 cause Aicardi-Gouti\u00e8res syndrome at the AGS1 locus","volume":"38","author":"Crow","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2019.102361_bb0240","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2017.03.001","article-title":"DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice","volume":"81","author":"Sakai","year":"2017","journal-title":"J Autoimmun"},{"issue":"12","key":"10.1016\/j.autrev.2019.102361_bb0245","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.autrev.2015.08.002","article-title":"Inherited anomalies of innate immune receptors in pediatric-onset inflammatory diseases","volume":"14","author":"Picard","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2019.102361_bb0250","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.2011.06220.x","article-title":"Type I interferonopathies: a novel set of inborn errors of immunity: type I interferonopathies","volume":"1238","author":"Crow","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.autrev.2019.102361_bb0255","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.revmed.2016.08.016","article-title":"Les interf\u00e9ronopathies de type I. Mise au point et revue de la litt\u00e9rature","volume":"39","author":"Picard","year":"2018","journal-title":"Rev Med Int"},{"issue":"12","key":"10.1016\/j.autrev.2019.102361_bb0260","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1084\/jem.20161596","article-title":"Type I interferon-mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview","volume":"213","author":"Rodero","year":"2016","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.autrev.2019.102361_bb0265","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1038\/s41467-017-01932-3","article-title":"Type I interferon-mediated autoinflammation due to DNase II deficiency","volume":"8","author":"Rodero","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.autrev.2019.102361_bb0270","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.chest.2016.02.682","article-title":"Severe pulmonary fibrosis as the first manifestation of interferonopathy (TMEM173 mutation)","volume":"150","author":"Picard","year":"2016","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.autrev.2019.102361_bb0275","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated STING in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.autrev.2019.102361_bb0280","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/art.40179","article-title":"Musculoskeletal disease in MDA5-related type I interferonopathy: a Mendelian mimic of Jaccoud's Arthropathy","volume":"69","author":"de Carvalho","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2019.102361_bb0285","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1084\/jem.20161451","article-title":"Detection of interferon alpha protein reveals differential levels and cellular sources in disease","volume":"214","author":"Rodero","year":"2017","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.autrev.2019.102361_bb0290","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1474-4422(13)70258-8","article-title":"Assessment of interferon-related biomarkers in Aicardi-Gouti\u00e8res syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study","volume":"12","author":"Rice","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2019.102361_bb0295","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cyto.2018.10.023","article-title":"Comparison of RT-qPCR and Nanostring in the measurement of blood interferon response for the diagnosis of type I interferonopathies","volume":"113","author":"Pescarmona","year":"2019","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.autrev.2019.102361_bb0300","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/jir.2017.0127","article-title":"Development of a validated interferon score using nanostring technology","volume":"38","author":"Kim","year":"2018","journal-title":"J Interferon Cytokine Res"},{"issue":"3","key":"10.1016\/j.autrev.2019.102361_bb0305","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.33368","article-title":"Mutations in proteasome subunit \u03b2 type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity: mutations in PSMB8 cause Candle syndrome","volume":"64","author":"Liu","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2019.102361_bb0310","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/ng.748","article-title":"Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature","volume":"43","author":"Briggs","year":"2011","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.autrev.2019.102361_bb0315","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.autrev.2008.07.040","article-title":"Altered T and B lymphocyte signaling pathways in lupus","volume":"8","author":"Peng","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"5215","key":"10.1016\/j.autrev.2019.102361_bb0320","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.autrev.2019.102361_bb0325","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7326\/0003-4819-130-7-199904060-00020","article-title":"An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome","volume":"130","author":"Straus","year":"1999","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.autrev.2019.102361_bb0330","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaci.2012.06.011","article-title":"Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation","volume":"131","author":"Magerus-Chatinet","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2019.102361_bb0335","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1182\/blood-2006-04-015776","article-title":"A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome","volume":"108","author":"Del-Rey","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.autrev.2019.102361_bb0340","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1172\/JCI118892","article-title":"Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease","volume":"98","author":"Wu","year":"1996","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.autrev.2019.102361_bb0345","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.176.6.1645","article-title":"Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci","volume":"176","author":"Watson","year":"1992","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.autrev.2019.102361_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.159.1.1","article-title":"A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H\/HeJ mice","volume":"159","author":"Roths","year":"1984","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.autrev.2019.102361_bb0355","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/ni.2016","article-title":"STIM1, PKC-\u03b4 and RasGRP set a threshold for proapoptotic Erk signaling during B cell development","volume":"12","author":"Limnander","year":"2011","journal-title":"Nat Immunol"},{"issue":"6883","key":"10.1016\/j.autrev.2019.102361_bb0360","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/416865a","article-title":"Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta","volume":"416","author":"Miyamoto","year":"2002","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.autrev.2019.102361_bb0365","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood-2012-12-469544","article-title":"Loss-of-function of the protein kinase C \u03b4 (PKC\u03b4) causes a B-cell lymphoproliferative syndrome in humans","volume":"121","author":"Kuehn","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.autrev.2019.102361_bb0370","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10875-015-0178-9","article-title":"Potentially beneficial effect of hydroxychloroquine in a patient with a novel mutation in protein kinase C\u03b4 deficiency","volume":"35","author":"Kiykim","year":"2015","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2019.102361_bb0375","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0781","article-title":"Early-onset juvenile SLE associated with a novel mutation in protein kinase C \u03b4","volume":"139","author":"Nanthapisal","year":"2017","journal-title":"Pediatrics"},{"issue":"16","key":"10.1016\/j.autrev.2019.102361_bb0380","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1182\/blood-2012-10-460741","article-title":"B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C \u03b4","volume":"121","author":"Salzer","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.autrev.2019.102361_bb0385","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.semarthrit.2013.04.009","article-title":"Are RASopathies new monogenic predisposing conditions to the development of systemic lupus erythematosus? Case report and systematic review of the literature","volume":"43","author":"Bader-Meunier","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2019.102361_bb0390","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaci.2016.09.029","article-title":"Abnormal hematopoiesis and autoimmunity in human subjects with germline IKZF1 mutations","volume":"140","author":"Hoshino","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2019.102361_bb0395","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJMoa1512234","article-title":"Loss of B cells in patients with heterozygous mutations in IKAROS","volume":"374","author":"Kuehn","year":"2016","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.autrev.2019.102361_bb0400","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1084\/jem.190.9.1201","article-title":"Defects in hemopoietic stem cell activity in Ikaros mutant mice","volume":"190","author":"Nichogiannopoulou","year":"1999","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.autrev.2019.102361_bb0405","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1074-7613(00)80269-1","article-title":"Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation","volume":"5","author":"Wang","year":"1996","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.autrev.2019.102361_bb0410","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jaci.2014.07.063","article-title":"Impaired receptor editing and heterozygous RAG2 mutation in a patient with systemic lupus erythematosus and erosive arthritis","volume":"135","author":"Walter","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2019.102361_bb0415","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nri.2016.28","article-title":"Human RAG mutations: biochemistry and clinical implications","volume":"16","author":"Notarangelo","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2019.102361_bb0420","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1084\/jem.188.4.627","article-title":"A human severe combined immunodeficiency (SCID) condition with increased sensitivity to ionizing radiations and impaired V(D)J rearrangements defines a new DNA recombination\/repair deficiency","volume":"188","author":"Nicolas","year":"1998","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.autrev.2019.102361_bb0425","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.autrev.2019.102361_bb0430","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jaci.2016.07.015","article-title":"Efficacy of the Janus kinase 1\/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children","volume":"138","author":"Fr\u00e9mond","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2019.102361_bb0435","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/art.39962","article-title":"Anifrolumab, an anti-interferon-\u03b1 receptor monoclonal antibody, in Moderate-to-severe systemic lupus erythematosus: ANIFROLUMAB IN MODERATE-TO-SEVERE SLE","volume":"69","author":"Furie","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"23","key":"10.1016\/j.autrev.2019.102361_bb0440","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMc1810983","article-title":"Reverse-transcriptase inhibitors in the Aicardi\u2013Gouti\u00e8res syndrome","volume":"379","author":"Rice","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.autrev.2019.102361_bb0445","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12969-018-0278-1","article-title":"Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C \u03b4","volume":"16","author":"Lei","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.autrev.2019.102361_bb0450","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jaci.2013.07.035","article-title":"Successful cure of C1q deficiency in human subjects treated with hematopoietic stem cell transplantation","volume":"133","author":"Arkwright","year":"2014","journal-title":"J Allergy Clin Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219301612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219301612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:16:00Z","timestamp":1761599760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997219301612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":90,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1568997219301612"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2019.102361","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monogenic lupus: Dissecting heterogeneity","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2019.102361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102361"}}